Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Agn 193109. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4-[2-[5,6-Dihydro-5,5-dimethyl-8-(4-methylphenyl)-2-naphthalenyl]ethynyl]benzoic Acid; CD 3106. Product Category: Heterocyclic Organic Compound. Appearance: Off-White Solid. CAS No. 171746-21-7. Molecular formula: C28H24O2. Mole weight: 392.49. Purity: 0.96. IUPACName: 4-[2-[5,5-dimethyl-8-(4-methylphenyl)-6H-naphthalen-2-yl]ethynyl]benzoic acid. Density: 1.21 g/cm³. Product ID: ACM171746217. Alfa Chemistry ISO 9001:2015 Certified.
AGN 193109 has been found to be a pan-retinoic acid receptor (RAR) antagonist. Synonyms: AGN 193109; AGN193109; AGN-193109; 4-[2-[5,6-Dihydro-5,5-dimethyl-8-(4-methylphenyl)-2-naphthalenyl]ethynyl]benzoic acid. Grades: ≥97% by HPLC. CAS No. 171746-21-7. Molecular formula: C28H24O2. Mole weight: 392.49.
AGN 193109
AGN 193109 is a retinoid analog, and acts as a specific and highly effective antagonist of retinoic acid receptors (RARs) , with K d s of 2 nM, 2 nM, and 3 nM for RARα , RARβ , and RARγ , respectively. AGN 193109 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. AGN 193109 is the antidote for retinoic acidosis, that ameliorates the skin and mucosal toxicity. Uses: Scientific research. Group: Signaling pathways. CAS No. 171746-21-7. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-U00449.
AGN 193109-d7
A labeled retinoic acid receptor (RAR) antagonist used for treating chemotherapy and radiation therapy side effects. Group: Biochemicals. Alternative Names: 4- [2- [5, 6-Dihydro-5, 5-dimethyl-8- (4-methylphenyl-d7) -2-naphthalenyl] ethynyl] benzoic Acid; CD 3106-d7. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences.
Worldwide
AGN 193109-d7 Ethyl Ester
Precursor to labeled AGN 193109. Group: Biochemicals. Alternative Names: 4- [2- [5, 6-Dihydro-5, 5-dimethyl-8- (4-methylphenyl-d7) -2-naphthalenyl] ethynyl] benzoic Acid Ethyl Ester. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences.
Worldwide
Agn 193109 ethyl ester
Agn 193109 ethyl ester. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4-[2-[5,6-Dihydro-5,5-dimethyl-8-(4-methylphenyl)-2-naphthalenyl]ethynyl]benzoic Acid Ethyl Ester. Product Category: Heterocyclic Organic Compound. Appearance: Pale Yellow Solid. CAS No. 171568-43-7. Molecular formula: C30H28O2. Mole weight: 420.54. Purity: 0.96. IUPACName: ethyl 4-[2-[5,5-dimethyl-8-(4-methylphenyl)-6H-naphthalen-2-yl]ethynyl]benzoate. Product ID: ACM171568437. Alfa Chemistry ISO 9001:2015 Certified.
AGN 193109 Ethyl Ester
Precursor to AGN 193109. Group: Biochemicals. Alternative Names: 4- [2- [5, 6-Dihydro-5, 5-dimethyl-8- (4-methylphenyl) -2-naphthalenyl] ethynyl] benzoic Acid Ethyl Ester. Grades: Highly Purified. CAS No. 171568-43-7. Pack Sizes: 1mg. US Biological Life Sciences.
Worldwide
AGN 193109 Sodium Salt
AGN 193109 is a potent antagonist of retinoic acid receptors (RARs, Kd = 2, 2, and 3 nM for RARα, β, and γ, respectively). Synonyms: 4-[2-[5,6-dihydro-5,5-dimethyl-8-(4-methylphenyl)-2-naphthalenyl]ethynyl]-benzoic acid monosodium salt; CD 3106 Sodium Salt; Benzoic acid, 4-[2-[5,6-dihydro-5,5-dimethyl-8-(4-methylphenyl)-2-naphthalenyl]ethynyl]-, sodium salt (1:1); sodium 4-((5,5-dimethyl-8-(p-tolyl)-5,6-dihydronaphthalen-2-yl)ethynyl)benzoate. Grades: 95%. Molecular formula: C28H23NaO2. Mole weight: 414.47.
AGN 193109 Sodium Salt
A retinoic acid receptor (RAR) antagonist used for treating chemotherapy and radiation therapy side effects. Group: Biochemicals. Alternative Names: 4- [2- [5, 6-Dihydro-5, 5-dimethyl-8- (4-methylphenyl) -2-naphthalenyl] ethynyl] benzoic Acid Sodium Salt; CD 3106 Sodium Salt. Grades: Highly Purified. CAS No. 171746-21-7(freebase). Pack Sizes: 1mg. US Biological Life Sciences.